Vidal M, Falato C, Pascual T, Sanchez-Bayona R, et al. Elacestrant in women with estrogen receptor-positive and HER2-negative early breast cancer: results from the preoperative window-of-opportunity ELIPSE trial. Clin Cancer Res 2025 Jan 16. doi: 10.1158/1078-0432.CCR-24-2460.
PMID: 39820652